You’re reading Significant Digits, a daily digest of the

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
167
Quote:
You’re reading Significant Digits, a daily digest of the numbers tucked inside the news.

11.8 percent

The U.S. Post Office saw a shipping and package income of $19.5 billion last year, which is up 11.8 percent compared to the previous year. It was a bright spot in an otherwise tough financial position brought about thanks to a decline in first class mail and high health benefit costs the USPS is forced to set aside.

Industry analysts believe about 40 percent of Amazon packages are delivered by the Postal Service and the company spent $21.7 billion on shipping costs in 2017. [The Washington Post]

37 percent

(Sponsored by Mott & Bow) When you’re picking out a pair of jeans, you probably look at things like size and color. Next time, pay attention to the stretch factor, too. The higher the stretch factor, the more versatile the jeans are.

* These Jeans have a sky-high stretch factor of 37 percent, allowing for comfort and freedom of movement without sacrificing the denim look.

* Actual name and $128/pair. I think I'll stick with 'Those Jeans', get 4 pair, do some squats, just f*ckin' wear them.

https://www.mottandbow.com/4-way-stretchaw?ut...cid=SigDig

38 percent

“Deadpool 2” won the box office and usurped “Avengers: Infinity War,” pulling in $125 million domestically and $176 million abroad in 81 markets, the biggest international opening for Fox ever. Market research indicated — and I don’t mean to shock you here — that the Deadpool movie’s audience skewed young (38 percent of ticket buyers were younger than 25) and male (61 percent). [The Hollywood Reporter]

60 plates per second

Automated license plate readers are devices that are mounted on police cars and can scan license plates — to the tune of up to 60 plates per second — and run those plates against a list of ones law enforcement suspects may be a potentially wanted or stolen vehicle.

It’s a Constitutionally grey area — the closest we get to precedence vis-a-vis the necessity of a warrant is a 1983 Supreme Court case — but that’s not stopping even more sophisticated versions of LPRs to hit the market, like a new upgrade from manufacturer ELSAG that allows the devices to identify “color, seven body types, 34 makes, and nine visual descriptors” on top of the plate. [Ars Technica]

42 percent

A study of the 34 scripted shows slotted to debut on network television this fall found that 42 percent of key roles went to women and an equal number went to people of color. This is up from the batch of shows debuting last fall, when 35 percent of key roles in scripted shows on ABC, CBS, the CW, Fox, and NBC went to women and only 20 percent went to people of color. [Variety]

60 percent

By dollar value, that’s the percentage of electronic components in the ZTE Axon M phone that originate from U.S. companies like Qualcomm, SanDisk, Skyworks Solutions and Corning. This poses a mild problem, given a U.S. ban on shipments of phone parts to ZTE began in mid-April. [The Wall Street Journal]

271 coin offerings


A Wall Street Journal analysis of 1,450 digital coin offerings — instances where firms raise money off of a new cryptocurrency — found that in 271 cases there were red flags like plagiarism in investor documents, missing or fake executives or implications of guaranteed money.

Those 271 iffy offerings have pulled in over a billion dollars from investors, which is an enormous chunk of the about $5 billion raised by the 1,450 coins studied. [The Wall Street Journal]

Thank you

Today is my last day with FiveThirtyEight; the column will continue, but this is the final edition of Significant Digits that I will write. I just want to personally thank you for reading. It’s been an enormous joy to work on this every day and interact with you all.

My next venture is Numlock News, and I hope you’ll check it out. Either way, thanks for waking up with Significant Digits — this project has meant so much to me and you all were a big reason why.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 132

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 70

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

WTW Welcomes Dale Porfilio as Director for Business Development

Updated Category News Views 138

WTW Appoints New Leader for Business Development In a significant move to enhance its operations, WTW (NASDAQ: WTW) has announced the appointment of Dale Porfilio as Senior Director and Head of Personal and Commercial Lines Business Development within its Insurance Consulting & Technology (ICT) segment. A Seasoned Professional Joins WTW Porfilio brings a wealth of...

Continue Reading
Jorgen Vig Knudstorp's Bold Stock Purchase at Starbucks

Updated Category News Views 74

Jorgen Vig Knudstorp Invests in Starbucks, Showing Strong Confidence Recently, Jorgen Vig Knudstorp, a director at Starbucks Corp (NASDAQ:SBUX), made a significant move by buying shares of the company. This act signals a firm vote of confidence in the future of the beloved coffee chain. When insiders make such investments, it often grabs the attention of other investors...

Continue Reading
Understanding Inventiva's Latest Half-Year Report and Future Plans

Updated Category News Views 65

Inventiva Files its 2024 Half-Year Report Inventiva, a prominent clinical-stage biopharmaceutical company, is making significant strides in the healthcare sector. Focused on developing oral therapies for metabolic dysfunction-associated steatohepatitis, commonly known as MASH/NASH, the company recently announced its filing of the 2024 Half-Year Report for the period...

Continue Reading
Analyzing Organon's Upcoming Earnings Announcement and Insights

Updated Category News Views 177

Anticipation Surrounding Organon's Earnings Report Organon (OGN) is on the verge of revealing its quarterly earnings report, a moment eagerly awaited by investors. As preparations finalize for this significant announcement, understanding the forecasted outcomes can guide investor decisions moving forward. Expected Earnings Figures Forecast estimates suggest that Organon...

Continue Reading
Miami Real Estate Trends: A Surge in Older Condo Sales

Updated Category News Views 180

Understanding the Miami-Dade Real Estate Market Miami-Dade County's real estate landscape is shifting, with older condominiums experiencing quicker sales than their newer counterparts. This trend indicates a solid demand for older condos, highlighting their appeal in a market where affordable housing options continue to thrive. Statistical data reveal that older...

Continue Reading